Dr. Strand serves as a consultant in clinical research and regulatory affairs to pharmaceutical and biotech companies. She has been a clinical rheumatologist for 35 years, in subspecialty practice in San Francisco, and a clinical investigator and subsequently, Senior Director of Clinical Research, at 3 pharmaceutical/biotech companies. She has served as Adjunct Clinical Professor, Division of Immunology and Rheumatology at Stanford University since September 2000; Clinical Associate Professor to March 1993, and Assistant and Associate Clinical Professor at the University of California San Francisco (1981-1993). Since 1991, she has consulted regarding translation of basic research into rational design of randomized controlled trials, analysis of their results, and presentation of novel products for approval to the FDA and EMA. She has assisted in preparation of briefing documents, analyses, and data presentation for defense of NDA and BLA applications in rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, spondyloarthropathy, scleroderma and systemic sclerosis, uveitis, osteoarthritis, gout, fibromyalgia syndrome, and the first monoclonal antibody biosimilar. She has been an invited member of FDA Arthritis Advisory Committee meetings discussing Guidance Documents.

She established and co-chaired the biyearly “Innovative Therapies in Autoimmune Disease” meetings cosponsored by American College of Rheumatology (ACR), NIH, and FDA (1988 – 2007). She has served as a founding member of the Executive Committee of the international OMERACT consensus conferences (1992–present). She is a member of the ACR RA Clinical Trials Task Force (2011–present), Board of Directors (2005–2013) and Medical and Scientific Committee of Northern California Chapter of the Arthritis Foundation (2005–present), Board of Directors of CORRONA (2002–2008), Scientific Advisory Board (2010–present) and Board of Advisors for ACTTION. She has authored over 335 original publications and is a Fellow of the American College of Physicians (1982), Master of the ACR (2015), member of the Cosmos Club (1994) and it’s Substitute Board of Managers (2013–present).